The Pharmaceutical Market: Thailand

Espicom Healthcare Intelligence
May 15, 2012
58 Pages - SKU: ESPI3909440
Countries covered: Thailand

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.

Specialised intelligence on OTCs, generics, biologics and biosimilars.

Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.

A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

Please Note: this is delivered as a Zip file.


Additional Information

THE PHARMACEUTICAL MARKET: THAILAND - REVIEW

The macroenvironment is positive for the Thai pharmaceutical market. Politically, Yingluck Shinawatra became Thailand’s first female Prime Minister in August 2011. Economically, the Economist Intelligence Unit (EIU) projects that Thailand will be the eighth largest economy in the Asia Pacific region by 2017. Legally, Thailand remained on the USTR’s Priority Watch List in 2011. Demographically, the EIU projects an annual growth rate of around 0.6% during the forecast period and the population will be the ninth largest in the Asia Pacific region by 2017. The elderly population is rising; Thailand is expected to have the eighth highest proportion in the Asia Pacific region in 2017.

Despite relying heavily on imports, Thailand’s pharmaceutical market is growing. The balance of pharmaceutical trade remains considerably negative, with retail medicaments accounting for over two-thirds of the total deficit. Between 2006 and 2010, the deficit in the balance of trade rose by a high double-digit CAGR. Thailand’s pharmaceutical market is estimated to grow at a low double-digit CAGR in US dollar terms between 2012 and 2017. Thailand will have the eighth largest pharmaceutical market in the Asia Pacific region in 2017. In per capita terms, Thailand is projected to have the eighth highest rate in the Asia Pacific region by 2017.

The Thai generic sector is growing, especially in the public sector, where the government has encouraged its use over patented drugs in order to cut costs. Greater Pharma has recently launched its first generic inhaler drug for the treatment of osteoporosis, making it the first company in Southeast Asia to successfully manufacture a generic version of this drug. The Thai biologic sector is very underdeveloped, but there are signs that this could change. The government-backed organisation BIOTEC has formed partnerships with both Greater Pharma and i+MED. Greater Pharma has developed the first biologic allergy vaccine in South-east Asia.

ENHANCED STRATEGIC INTELLIGENCE

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

Related Pages:

Pharmaceutical Market Taiwan

Pharmaceutical Market Vietnam

More Information...

HIGHLY DETAILED REPORT CONTENT

EXECUTIVE SUMMARY
Including Espicom's at a glance strategic analysis and key data projections

MACROENVIRONMENT
Political, economic, legal and demographic analysis

EPIDEMIOLOGY
Disease burden and prevalence

HEALTHCARE
Organisation, expenditure, infrastructure, services and workforce

REGULATORY AFFAIRS
Regulatory developments and marketing registration/authorisation

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET ANALYSIS
Projections, product development, manufacturing and trade

COMPETITION
Trade associations, trade fairs, company intelligence and competitive strategies

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

OPPORTUNITIES & CHALLENGES
Espicom's unique strategic analysis

DIRECTORY

METHODOLOGY & SOURCES

More Pricing reports by Espicom Healthcare Intelligence

The Worldwide Guide to Pricing & Reimbursement by Espicom Healthcare Intelligence
Provides insight into pharmaceutical pricing and reimbursement systems around the world! ...
The Pharmaceutical Market: Vietnam by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Venezuela by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: USA by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 1,085  
    Global Site License  USD 7,095  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!